Page last updated: 2024-11-03

probenecid and Virus Diseases

probenecid has been researched along with Virus Diseases in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Virus Diseases: A general term for diseases caused by viruses.

Research Excerpts

ExcerptRelevanceReference
" Concentrations of cidofovir in kidney declined with a half-life of 23 hr and were > 1,000-fold higher than plasma levels by 120 hr."1.29Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug. ( Cundy, KC; Hitchcock, MJ; Lee, WA; Li, ZH, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, MU1
Bennett, DJ1
Hsieh, TC1
Doonan, BB1
Ahmed, S1
Wu, JM1
Cundy, KC1
Li, ZH1
Hitchcock, MJ1
Lee, WA1

Reviews

1 review available for probenecid and Virus Diseases

ArticleYear
Repositioning of drugs using open-access data portal DTome: A test case with probenecid (Review).
    International journal of molecular medicine, 2016, Volume: 37, Issue:1

    Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Antiviral Agents; Databases, Pharmaceutical

2016

Other Studies

1 other study available for probenecid and Virus Diseases

ArticleYear
Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug.
    Drug metabolism and disposition: the biological fate of chemicals, 1996, Volume: 24, Issue:7

    Topics: Administration, Cutaneous; Administration, Oral; Animals; Antiviral Agents; Biological Availability;

1996